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Abstract 
Purpose: To evaluate the usefulness of the flow-through cell apparatus for testing commercial vaginal 
tablets containing poorly water-soluble clotrimazole.  
Methods: The effect of experimental conditions (type of dissolution medium, flow rate and positioning of 
the tablet) on the dissolution profile of clotrimazole were examined and optimal parameters for 
conducting the experiments were determined. The amount of drug released was analyzed by high 
performance chromatography (HPLC) at 210 nm. The usefulness of the flow-through cell apparatus was 
compared to FDA recommended paddle apparatus.   
Results: Using acetate buffer pH 5.2 containing 1 % SDS, both methods gave different dissolution 
profiles. The paddle apparatus tended to give faster rate of dissolution (approx. 88.5 % during the first 
20 min of the experiment), which was probably caused by higher agitation and greater surface area of 
the drug-dissolution medium in a vessel. In the flow-through cell method, total drug release was 
definitely slower and was observed after 2 to 5 h; at a flow rate of 16 ml/min, more than 80 % of the 
drug dissolved after 30 min of the test. It was noticed that raising the flow rate of the dissolution medium 
caused significantly higher drug release. 
Conclusion: The results demonstrate that the flow-through cell method is reproducible and can be 
successfully used for evaluating in vitro dissolution of clotrimazole from non-modified release tablets. 
The slower rate of dissolution obtained in the flow-through cell method would help to distinguish 
between different formulations. 
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In vitro dissolution study is an official test for 
evaluating drug release from tablet and capsule 
dosage forms. It is important in process control, 
quality assurance and to determine reliable 
release characteristics of the product over time 
[1,2]. Dissolution tests have also been applied as 
a tool to predict drug product performance in vivo 
as a result of attempts to minimize costly in vivo 
bioequivalence studies required to approve a 
new drug product [3,4]. The basket and paddle 
methods are currently the most widely used 
dissolution techniques. However, both display 
several disadvantages, e.g., hydrodynamic 
disturbance or finite sink conditions [5,6].  
 
The flow-through cell apparatus is a relatively 
new method for dissolution studies and has been 
officially included in the United States and 
European Pharmacopeia as apparatus 4 [2,7]. It 
consists of a pump which forces the release 
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medium upwards through a vertically positioned 
flow-through cell, a water bath and a reservoir 
filled with the release medium [8,9]. In spite of 
the fact that a variety of combinations and the 
diversity of available cell types allow the 
application of this apparatus for testing wide 
range of dosage forms, the flow-through cell 
method is particularly favoured for the in vitro 
dissolution studies of poorly water-soluble drugs 
and sustained release dosage forms due to its 
ability to maintain sink conditions during the test 
[5,8]. In the flow-through cell method, there are 
no problems with sampling and no further 
filtration steps are needed as the sample solution 
is automatically filtered upon leaving the cell [5].  
Although there are many reports in the literature 
describing the suitability of apparatus 4 as 
dissolution method for various dosage forms [10-
12], no standard pharmacopeial tests on the use 
of this apparatus for non-modified release drugs 
are available [2,7,13]. Therefore, the aim of this 
study was to evaluate the usefulness of the flow-
through cell method (apparatus 4) for testing 
commercially available vaginal tablets containing 
a poorly water-soluble drug, clotrimazole, 
intended for immediate drug release vis-a-vis the 
FDA recommended paddle method [13]. Since 
the United States and European Pharmacopeia 
provide only limited information about apparatus 
4 test conditions, the influence of some 
experimental parameters, such as type of 
dissolution medium, flow rate and positioning of 
the tablet, on the dissolution profile of 






Clotrimazole was kindly given by Aflofarm, 
Pabianice, Poland. Acetic acid (80 %),  
hydrochloric acid (35 - 38 %), sodium acetate, 
potassium dihydrogen phosphate, sodium 
hydroxide and disodium hydrogen phosphate 
were obtained from Chempur, Piekary Slaskie, 
Poland. Sodium dodecyl sulfate (SDS) was 
purchased from POCH, Gliwice, Poland. 
Methanol (HPLC grade) was purchased from 
Merck, Darmstadt, Germany. Water for HPLC 
was distilled and passed through a reverse 
osmosis system (Milli-Q Reagent Water System, 
Billerica, USA). Commercially available vaginal 
tablets containing clotrimazole 100 mg were 
purchased locally (Clotrimazolum GSK, 
GlaxoSmithKline Pharmaceuticals SA, batch no: 
RB 2361, expiry date: 02.2014). The excipients 
in formulating the tablets include lactose 
monohydrate, potato starch, adipic acid, sodium 
bicarbonate, magnesium stearate, colloidal 
silicon dioxide, sodium dodecyl sulphate. 
Clotrimazole solubility studies 
 
The solubility of clotrimazole was checked in 
different media – distilled water, 0.1M HCl (pH 
1.4, acetate buffer (pH 5.2) and acetate buffer 
(pH 5.2) incorporating 1 % SDS. Excess amount 
of the drug (5 mg) was placed in a glass conical 
flask with 20 ml of appropriate medium. The 
flasks were agitated for 24 h in a shaker water 
bath at 25 ± 0.5 °C at a speed of 250 rpm. The 
saturated drug solution was centrifuged at 4000 
rpm for 20 min. Samples (1 ml) were withdrawn 
from the supernatant, suitably diluted with 
methanol, filtered through a 0.45 µm CA 
(cellulose acetate) membrane filter paper  (GVS 
Filter Technology, Indianapolis, IN, USA) and 
analyzed by high performance liquid 
chromatography (HPLC) (Agilent Technologies 
1200, Agilent, Waldbronn, Germany). All 
experiments were conducted in triplicate. 
 
Disintegration time study 
 
Disintegration study of the vaginal tablets was 
carried out according to European Pharmacopeia 
[2] in 0.1M HCl or acetate buffer (pH 5.2) with 1 
% SDS, maintained at 37 ± 0.5 °C. A 
disintegration tester, Electolab ED-2L (India) 
consisting of a basket-rack assembly, was used. 
Six tablets were used in each test. Complete 
disintegration of the tablets was observed 
visually and the time taken was noted.  
 
Dissolution study by paddle method 
(apparatus 2) 
 
Vaginal tablets with clotrimazole were placed 
directly into six vessels of the dissolution tester 
(Erweka Paddle Dissolution Tester, type DT 
600HH, Heusenstamm, Germany), each 
containing 900 ml of the dissolution medium 
(Table 1). Samples (5 ml) were withdrawn at 
predetermined time intervals, filtered through a 
0.45 µm CA filter paper, diluted with methanol 
and analyzed by HPLC. Withdrawn samples 
were replaced with equivalent volume of fresh 
dissolution medium. Studies were conducted in 
triplicate. 
 
Dissolution study by flow-through cell 
method (apparatus 4) 
 
Erweka Flow-Through Cell Dissolution Tester, 
type DFZ 720 (Heusenstamm, Germany) 
equipped with 22.6 mm diameter cells was used. 
One glass bead of 5 mm diameter and 5 g of 
beads of 1 mm diameter were placed in the 
sample cell to fill the bottom conical part. Vaginal 
tablets were situated either directly on glass 
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beads or positioned uniformly in a tablet clip 
holder to determine the effect of positioning the 
dosage form within the cell. The appropriate 
release medium was circulated in an open-loop 
configuration, so fresh medium was continuously 
pumped through the flow cell. The effect of flow 
rate on drug release was evaluated at flow rates 
between 4 and 16 ml/min. Fractions of the 
dissolution medium were collected and at the 
predetermined time points 1 ml samples were 
withdrawn, diluted with methanol and analyzed 
by HPLC. Studies were carried out in triplicate. 
 
Table 1:  Dissolution test conditions used for the test 
methods 
 
Parameter Paddle Flow-through cell 
Dissolution medium 0.1 M HCl
* or acetate buffer 
pH 5.2 + 1 % SDS 
Temperature 37 ± 0.5 °C 
Paddle rotation 50 rpm* - 
Flow rate - 4, 8 or 16 ml/min 
Rotation speed - 120 rpm 
Sampling 10, 20, 
30, 45 
min* 
10, 20, 30, 45 
min;                          
1, 2, 3, 4, 5 h 
Detection HPLC at λ = 210 nm 
* FDA recommendation [13] 
 
HPLC analysis of clotrimazole 
 
The concentration of clotrimazole in the 
dissolution medium was determined by a HPLC 
system (Agilent Technologies 1200) equipped 
with a G1312A binary pump, a G1316A 
thermostat, a G1379B degasser and a G1315B 
diode array detector (Agilent, Waldbronn, 
Germany). Data collection and analysis were 
performed using Chemstation 6.0 software. 
Isocratic separation was achieved on a Zorbax 
Eclipse XDB–C18, 4.6x150 mm, 5 µm column 
(Agilent, Waldbronn, Germany). Mobile phase 
was methanol – phosphate buffer (pH 7.4, 4:1 
v/v), flow rate 1.0 ml/min and UV detection was 
performed at a wavelength of 210 nm [14,15]. 
Column temperature was maintained at 25 ºC. 
For injection into the HPLC system, 20 µl of 
sample was used. All reagents used for analysis 
were of HPLC grade. The retention time of 
clotrimazole was 5.2 min. Standard solutions for 
calibration curve were prepared in 0.1M HCl or in 




The results were expressed as mean ± standard 
deviation (SD). The analysis was performed 
using the analysis of variance (ANOVA) and 
multiple comparisons were made to check 
statistical significance using Statistica 8.0 
software. Differences were considered to be 




Solubility of clotrimazole 
 
The solubility of clotrimazole in distilled water 
and acetate buffer pH 5.2 without surfactant 
(SDS) was very low, being 0.38 and 4.46 µg/ml, 
respectively, but much higher in 0.1M HCl (527.0 
µg/ml) and in acetate buffer pH 5.2 containing 1 
% SDS (527.4 µg/ml).  
 
Tablet disintegration time 
 
Complete disintegration of the tablets in 0.1 M 
HCl was occurred after 5 ± 0.4 min, and in 
acetate buffer pH 5.2 containing 1 % SDS, this 
was achieved after 8 ± 0.6 min. 
 
In vitro release by paddle method 
 
Figure 1 presents the dissolution profiles of 
clotrimazole in 0.1 M HCl and acetate buffer pH 


























Figure 1: Clotrimazole dissolution profiles obtained by 
paddle method. Each value represents mean ± SD (n 
= 6) (Key:  = 0.1 M HCl;   = acetate buffer pH 5.2 
with 1 % SDS) 
Faster release was observed in the medium 
recommended by FDA (0.1M HCl) [13] in which 100 % 
of the drug dissolved during the first 10 min of the test. 
In acetate buffer containing surfactant (1 % SDS), 
88.52% of clotrimazole was released during the first 
20 min of the study. 
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Figure 2: Clotrimazole dissolution profiles obtained by 
flow-through cell method in acetate buffer (pH 5.2) 
containing 1 % SDS at flow rate of 4 ml/min (▲); 8 
ml/min (●); and 16 ml/min (■). Each value represents 
mean ± SD (n = 6)  
 
In vitro release by flow-through cell method 
 
Figure 2 shows a comparison of the dissolution 
profiles of clotrimazole obtained at various flow 
rates (4, 8 and 16 ml/min) in acetate buffer (pH 
5.2) containing 1 % SDS. 
 
The fastest release was observed with the flow 
rate at 16 ml/min, where about 83.4% of 
clotrimazole was released after 30 min of the 
investigation, whereas with the flow rate at 4 
ml/min and 8 ml/min only about 60.7% and 
75.5% of the drug dissolved at the end of first 
hour. As it is presented in Figure 3, using 
apparatus 4, a faster release was observed in 
0.1 M HCl - 85.9 % after 10 min of the 
experiment. In comparison with acetate buffer pH 
5.2 with 1 % SDS more than 80 % of the drug 
was released during 30 min. 
 
Figure 4 represents dissolution profiles of 
clotrimazole in acetate buffer pH 5.2 containing 1 
% SDS from tablets situated differently in the cell 
during the test.  
 
It was noticed that rates of dissolution obtained 
for tablets placed uniformly in a clip holder or 
directly in glass beads were similar (83.4 % 




Selecting a dissolution medium that suitably 
simulates in vivo conditions is one of the 
challenges in developing a good dissolution 
method. According to FDA guideline, 0.1M HCl is 
advised as the dissolution medium for vaginal 
tablets of clotrimazole [13]. Based on solubility 
data, clotrimazole exhibited comparable solubility 
in 0.1M HCl and acetate buffer (pH 5.2) 





























Figure 3: Clotrimazole dissolution profiles obtained by 
flow-through cell at constant flow rate of 16 ml/min.in 
0.1M HCl (●) and acetate buffer pH 5.2 with 1 % SDS 



























Figure 4: Clotrimazole dissolution profiles obtained by 
flow-through cell method in acetate buffer pH 5.2 
containing 1 % SDS at a constant flow rate of 16 
ml/min. The tablets were positioned uniformly in a clip 
holder (F1, ●) or situated directly on the glass beads 
(F2, ■). Each value represents mean ± SD (n = 6). 
 
0.1 M HCl is strongly acidic with a pH of about 
1.4, which ordinarily would be an inadequate 
medium since it is not close to vaginal pH  (pH 4 
- 5) [16], and therefore, clotrimazole may 
eventually be degraded in such a harsh 
environment. Therefore, acetate buffer pH 5.2 
with 1 % SDS was selected for further studies as 
the pH value better imitates vaginal conditions. 
In the paddle method, it was found that although 
almost 100 % of clotrimazole was released in 
0.1M HCl within the first 10 min of the test, a 
precipitation of components of the tablet in this 
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medium occurred. As a result, the sampling 
process was hindered as the sampling probes 
withdrawing from the vessels were coated with 
the precipitates. 
 
In the presence of acetate buffer pH 5.2 
containing 1 % SDS, insoluble components were 
found to sediment just after disintegration of the 
tablet, so a transparent medium with no floating 
particles was observed during the dissolution 
studies. More than 80 % of the drug was 
released during first 20 min of the study and the 
total amount of clotrimazole was released in 45 
min - the limit recommended by FDA and 
European Pharmacopeias [2,7,13].  
 
In the flow-through cell method, the time taken to 
achieve total drug release varied from 2 to 5 h, 
and was affected mainly by the applied flow rate. 
It was observed that  drug dissolution was a 
direct function of the flow rate. Significantly (p < 
0.05) faster release was noticed at a flow rate of 
16 ml/min, and hence this flow rate was used in 
further experiments.  
 
Two media, 0.1M HCl or acetate buffer (pH 5.2) 
containing 1 % SDS gave different dissolution 
profiles in the paddle method, with the paddle 
method giving significantly (p< 0.05) higher 
dissolution rates. This is probably due to higher 
agitation rate and greater surface area of the 
drug-dissolution medium interface in the vessel. 
Similar observations were made in dissolution 
experiments with gelatin capsules containing a 
poorly water soluble amine drug [11]. In the flow-
through cell method faster release was observed 
in 0.1 M HCl (85.9 % in 10 min) when compared 
to the acetate buffer pH 5.2 with 1 % SDS (> 80 
% of the drug released in 30 min). The slower 
rate of dissolution observed in acetate buffer (pH 
5.2) with 1 % SDS is helpful to distinguish 
between different formulations and may be 
explained by longer disintegration time of the 
tablets in this medium. The total disintegration of 
the tablet in 0.1 M HCl and acetate buffer pH 5.2 
with 1 % SDS was observed after about 5 and 8 
min, respectively.  
 
Different positioning of tablets did not remarkably 
influence the dissolution profile of clotrimazole. 
The solid/liquid interface - the point of contact 
between fresh solvent and the surface of the 
solid - is the key dissolution parameter. The flow-
through cell apparatus can present different 
environments to the sample - without glass 
beads in the entry cone, turbulent conditions and 
using glass beads, laminar flow conditions have 
been achieved [17]. The tablet can be placed 
upon glass beads or with a wire holder facilitating 
placement of the tablet approximately midway 
along the cylindrical part. It was shown that 
various positioning of tablets did not remarkably 
influence the dissolution profile of clotrimazole 
indicating that when glass beads are used, 
laminar and homogenous flow are achieved and 
stable hydrodynamic conditions are provided. 
These results are comparable with previously 
reported studies on prednisone tablets, where 
where it was found that there was no difference 
in release rate when the tablet was left free on 




Although the paddle method tended to give 
higher dissolution rates, the flow-through cell 
method showed reproducibility and may be 
successfully used for evaluating the in vitro 
dissolution of clotrimazole from non-modified 
release tablets. Flow rate and type of dissolution 
medium exert a fundamental influence on 
dissolution profile, but different positioning of the 
tablet in the cell did not have significant impact 
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